Priority Date: 24.05.16 (US 201662340560P)

ANTI-PAD4 AUTOANTIBODIES AS CLINICAL RESPONSE BIOMARKERS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

  • Application ID: EP17727829
  • Status: Request for examination was made

Applicant

Technology company logo small
Technology Company

Attorney

operating since 1848
Headquarter in London and 2 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC combination A61, C07, and G01. We found, that TransMIT GmbH, Kailuweit & Uhlemann, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Avidity IP Ltd, Mewburn Ellis LLP and 54 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 24.05.2016 - Priority Date (US 201662340560P)
  • 30.11.2017 - Publication A1 (WO2017202879)
  • 10.04.2019 - Publication A1 (EP3464358)